Trial Profile
A double-blind, randomized, placebo-controlled, two-period crossover study to explore the effect of levocarnitine (LC) on vismodegib-associated muscle spasms
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 May 2018
Price :
$35
*
At a glance
- Drugs Levocarnitine (Primary)
- Indications Basal cell cancer
- Focus Adverse reactions; Therapeutic Use
- 10 May 2018 New trial record